点击图片查看原图
杭州正大滤芯
GE Biacore T200生物大分子相互作用分
Sage ELF 全自动DNA片段连续回收系统
[VIP第1年] 指数:2
通过广州市黄埔区市场和质量监督管理局认证 
2×SSC缓冲液
细菌总蛋白抽提试剂
Human Hemopexin/HPX 
Integrin β1/CD29/IT
Caspase-4 Inhibitor 
Protein Deglycase (D| 货号： | 10006908 |
| 数量： | 大量 |
| 供应商： | 广州威佳科技有限公司 |
| 规格： | 1 ea |
| Obesity is a growing concern worldwide and has reached epidemic proportions in the United States.1 It is a risk factor in many major chronic diseases that afflict our society, including cardiovascular disease, diabetes mellitus, and cancer. In recent years, numerous studies have focused on identifying the mechanism of development of obesity, which is a process of either increasing the number of fat cells (fat cell hyperplasia) or enlargement of fat cells with each cell carrying greater amounts of fat (fat cell hypertrophy), or both.2,1 The ability to regulate the cell cycle and differentiation of adipocytes are key in the development and physiology of obesity and also in the origin of cancer. Understanding of these processes is critical to a rational approach to the treatment of obesity and cancer. Cayman’s Adipogenesis Assay Kit provides the reagents required for studying the induction and inhibition of adipogenesis in the established 3T3-L1 model, using the adipogenesis induction procedure. This kit can also be used to screen drug candidates involved in adipogenesis. The classic Oil Red O staining for lipid droplets is used in this kit as an indicator of the degree of adipogenesis, and can be quantified with a plate reader after the dye is conveniently extracted from the lipid droplet. |
| 1 Camp, H.S., Ren, D., Leff, T. Adipogenesis and fat-cell function in obesity and diabetes. Trends Mol Med 8(9) 442-447 (2002). 2 Spiegelman, B.M., Flier, J.S. Adipogenesis and obesity: Rounding out the big picture. Cell 87 377-389 (1995). |
